John Boozman sold Accenture plc (NYSE: ACN)
John Boozman (R-AR), a U.S. Senator, has disclosed 1 trade in Accenture plc (ACN) since 2026, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: John Boozman sold $1,001 - $15,000 of Accenture plc (NYSE: ACN) on May 15, 2026. Since that trade, ACN is up +2.58% against the S&P 500 down -1.31%, an outperformance of +3.89%.
Data updated
John Boozman's ACN trades vs the price
ACN is up +2.58% since John Boozman sold on May 15, 2026, versus -1.31% for the S&P 500.
Performance since this trade
All John Boozman ACN trades
John Boozman & ACN trading FAQ
Is it legal for John Boozman to trade Accenture plc (ACN) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Accenture plc (ACN), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did John Boozman sell ACN?
John Boozman disclosed a sale of $1,001 - $15,000 of Accenture plc (ACN) on May 15, 2026, according to public STOCK Act filings.
How has ACN performed since John Boozman's trade?
Since John Boozman sold ACN on May 15, 2026, the stock is up +2.58%, versus -1.31% for the S&P 500 over the same period, an outperformance of +3.89%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional ACN trades?
Quantellect tracks every disclosed congressional trade in Accenture plc (ACN) on the Accenture plc congressional trading page, which aggregates filings across all members of Congress.
John Boozman's ACN tradesAll congressional filings for Accenture plcJohn Boozman's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.